PFE Reiterated 'Strong Buy' at Gruntal, 'Strong Buy' at SG Cowen & 'Buy' at ABN AMRO:-
Bloomberg News
August 17, 1998, 11:22 a.m. ET
Princeton, New Jersey, Aug. 17 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated ''strong buy'' by analyst David F. Saks at Gruntal & Co.
- - Donna McDonald in Princeton, New Jersey, (609)279-3731
Bloomberg News
August 17, 1998, 10:58 a.m. ET
Princeton, New Jersey, Aug. 17 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated ''strong buy'' by analyst Steve Scala at SG Cowen.
- - Andrew Bekoff in Princeton, New Jersey, (609)279-3652
Bloomberg News
August 17, 1998, 1:32 p.m. ET
Princeton, New Jersey, Aug. 17 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated ''buy'' by analyst James P. Keeney at ABN AMRO.
-- Sybil Carlson in Princeton, New Jersey, (609)279-3615
[the following is an excerpt from a Bloomberg article "Equity Movers" at 2:28 p.m. ET]
Pfizer Inc. (PFE) rose as much as 1 7/16 to 102 5/8 on an
inflow of $10.3 million as analyst David Saks at Gruntal & Co.
reiterated a ''strong buy'' rating on the drugmaker and said he
could see its stock price reaching 148 in a year. Saks said the
company's now streamlined to maximize profit growth in its core
drug business, and will use some divestiture proceeds to develop
research collaborations that will make the company an even more
''formidable'' competitor.
|
